Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NK/T Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01667302
What this trial is testing

Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Not applicableWithdrawnNCT00513188
What this trial is testing

Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
University of Miami
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Not applicableNot Yet RecruitingNCT06863441
What this trial is testing

The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma

Who this might be right for
T-NK Cell Lymphoma
Ruijin Hospital 50
Early research (Phase 1)Study completedNCT00697346
What this trial is testing

Study of MLN8237 in Participants With Advanced Hematological Malignancies

Who this might be right for
B-cell Follicular LymphomaB-cell Marginal Zone LymphomaDiffuse Large B-cell Lymphoma+10 more
Millennium Pharmaceuticals, Inc. 58
Testing effectiveness (Phase 2)UnknownNCT03671850
What this trial is testing

VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients

Who this might be right for
Extranodal NK/T-cell Lymphoma
ViGenCell Inc. 48
Early research (Phase 1)Study completedNCT01445535
What this trial is testing

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

Who this might be right for
T-Cell Peripheral LymphomaGamma Delta Hepatosplenic T-Cell LymphomaSubcutaneous Panniculitis-Like T-Cell Lymphoma+1 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT01178658
What this trial is testing

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Seoul National University Hospital 42
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Early research (Phase 1)Looking for participantsNCT06696846
What this trial is testing

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory T-cell LymphomaRelapsed/Refractory Acute Myeloid Leukemia
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Not applicableEnded earlyNCT00514722
What this trial is testing

Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 4
Testing effectiveness (Phase 2)Ended earlyNCT05255601
What this trial is testing

Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin Disease
Bristol-Myers Squibb 5
Very early researchLooking for participantsNCT07162012
What this trial is testing

Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma

Who this might be right for
NK/T-cell LymphomaPeripheral T-cell Lymphoma (PTCL)DLBCL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Early research (Phase 1)Ended earlyNCT01116154
What this trial is testing

Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more
City of Hope Medical Center 30
Early research (Phase 1)Ended earlyNCT00101205
What this trial is testing

Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+24 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT05316246
What this trial is testing

Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell Lymphoma

Who this might be right for
NK/T Cell Lymphoma Nos
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Testing effectiveness (Phase 2)UnknownNCT04676789
What this trial is testing

Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573151
What this trial is testing

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

Who this might be right for
Lymphoma
Ruijin Hospital 28
Next Page